ABIOMED Story Overview

ABMD -- USA Stock  

USD 368.90  7.85  2.08%

Macroaxis does not monitor all media channels or aggregates social signals for ABIOMED. But even though we do not provide professional-grade financial sentiment analysis on ABIOMED, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for ABIOMED. Check also ABIOMED Hype Analysis, ABIOMED Correlation and ABIOMED Performance.
ABIOMED exotic insider transaction detected
Filed transaction by Abiomed Inc director. Unconventional Insider trading

ABIOMED Inc insider trading alert for general transaction of stock option (right to buy) by Martin Sutter, the corporate stakeholder, on January 3, 2018. This event was filed by Abiomed Inc with SEC on 2018-01-03. Statement of changes in beneficial ownership - SEC Form 4

Story Momentum

This media report from MacroaxisInsider distributed on January 3, 2018 was a factor to the next trading day price appreciation.The overall trading delta against the next closing price was 1.75% . The overall trading delta when the story was published against the current closing price is 92.52% .

Similar stores for ABIOMED

a day ago at http://simplywall.st 
How Do Analysts See ABIOMED Inc Performing In The Next 12 Months
news
Simply Wall StEquity Focus Investors Keen on Shares of ABIOMED, Inc. as it Makes Headlines With Moves The Coin GuildFull coverage
few days ago at www.macroaxis.com 
ABIOMED exotic insider transaction detected
Macroaxis News
Filed transaction by the entity director. Unconventional Insider trading
six days ago at www.macroaxis.com 
Sale by David Weber of 605 shares of ABIOMED
Macroaxis News
Filed transaction by Abiomed Inc officer. General open market or private sale of non-derivative or derivative security
over a week ago at www.macroaxis.com 
ABIOMED exotic insider transaction detected
Macroaxis News
Filed transaction by Abiomed Inc officer. Unconventional Insider trading
over two weeks ago at www.macroaxis.com 
ABIOMED exotic insider transaction detected
Macroaxis News
Filed transaction by Abiomed Inc director. Unconventional Insider trading
over two weeks ago at http://cardinalweekly.com 
As Abiomed Market Value Rose, Holder Coe Capital Management Has Cut by 408855 Its Position ...
news
The Cardinal Weekly Full coverage
over two weeks ago at www.macroaxis.com 
ABIOMED exotic insider transaction detected
Macroaxis News
Filed transaction by Abiomed Inc officer. Unconventional Insider trading
over three weeks ago at http://www.thecoinguild.com 
Market Focus Investors Focusing on Shares of ABIOMED, Inc. as Company Makes Headlines With ...
news
The Coin GuildFull coverage
over three weeks ago at www.macroaxis.com 
ABIOMED exotic insider transaction detected
Macroaxis News
Filed transaction by Abiomed Inc director. Unconventional Insider trading
over a month ago at www.macroaxis.com 
ABIOMED exotic insider transaction detected
Macroaxis News
Filed transaction by Abiomed Inc officer. Unconventional Insider trading
over a month ago at www.macroaxis.com 
Payment of 646 shares by Van Gorder Chris of ABIOMED subject to Rule 16b-3
Macroaxis News
Filed transaction by Abiomed Inc director. Payment of exercise price or tax liability by delivering or withholding securities
over two months ago at www.macroaxis.com 
Acquisition by Van Gorder Chris of tradable shares of ABIOMED subject to Rule 16b-3
Macroaxis News
Filed transaction by Abiomed Inc director. Grant, award or other acquisition pursuant to Rule 16b-3
over three months ago at http://ledgergazette.com 
Abiomed Holdings Cut by American Century Companies Inc.
news
The Ledger GazetteWhats Propelling ABIOMED, Inc. to Reach All-Time High Finance News DailyABIOMED, Inc. Reaches 1.36 52-Week High Dignity plc Had 0 Bullish Analysts Key GazetteBenzingas Daily Biotech Pulse FDA Panel Nod For Akcea, Synergys Revenue Miss, FDA Warns E-Liquid Makers Again BenzingaFull coverage

Return On Equity

Return On Equity Comparative Analysis

ABIOMED is currently under evaluation in return on equity category among related companies. Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how effecently a company utilizes investments to generate income.

Peers

ABIOMED Related Equities

DYNT  14.81 %   
0%
100.0%
ESTA  6.17 %   
0%
41.0%
ECIA  5.00 %   
0%
33.0%
EYES  3.95 %   
0%
26.0%
DRAD  3.33 %   
0%
22.0%
ELMD  1.18 %   
0%
7.0%
EW  0.23 %   
0%
1.0%
EDAP  2.56 %   
17.0%
0%
ESMC  8 %   
54.0%
0%
Check also ABIOMED Hype Analysis, ABIOMED Correlation and ABIOMED Performance. Please also try Equity Analysis module to research over 250,000 global equities including funds, stocks and etfs to find investment opportunities.
Search macroaxis.com